Literature DB >> 17321572

Pelvic and aortic lymph node metastasis in epithelial ovarian cancer.

Augusto Pereira1, Javier F Magrina, Victoria Rey, Manuel Cortes, Paul M Magtibay.   

Abstract

OBJECTIVE: The appropriate management of advanced ovarian cancer has been controversial in recent years. There are no adequate data about the importance of lymphadenectomy and the appropriate sites for lymph node assessment. We sought to evaluate the distribution, size, and number of pelvic and aortic lymph node metastases in patients with epithelial ovarian carcinoma.
METHODS: Retrospective chart review of 116 patients with stage IIIC or IV epithelial ovarian carcinoma treated at Mayo Clinic who underwent systematic bilateral pelvic and aortic lymphadenectomy between 1996 and 2000.
RESULTS: Eighty-six (78%) of 110 patients who underwent pelvic lymphadenectomy were found to have nodal metastases in 422 (16%) of 2705 pelvic nodes that were removed. Eighty-four (84%) of 100 patients had documented aortic lymph node metastases in 456 (35%) of 1313 aortic nodes that were removed. Fifty-five (59%) of 94 patients had bilateral metastatic pelvic and aortic lymph nodes and bilateral aortic lymphadenectomy was conducted in 53 (72%) of 74 patients. The most representative group for detection of nodal metastases was the aortic group (83%) followed by the external iliac group (59%) and the obturator nodes (53%). There was no significant difference between the mean size of positive (1.8 cm) and negative nodes (1.6 cm). Thirty-seven patients had unilateral tumor, and 1 patient (7%) had contralateral node metastasis.
CONCLUSION: The incidence of positive nodes bilaterally and positive high aortic nodes indicates the need for bilateral pelvic and aortic node dissection (extending above the inferior mesenteric artery) in all patients regardless of laterality of the primary tumor.

Entities:  

Mesh:

Year:  2007        PMID: 17321572     DOI: 10.1016/j.ygyno.2007.01.028

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma.

Authors:  Yuji Takei; Suzuyo Takahashi; Shizuo Machida; Akiyo Taneichi; Takahiro Yoshiba; Yoshifumi Takahashi; Chikako Yoshida; Yasushi Saga; Shigeki Matsubara; Hiroyuki Fujiwara
Journal:  Int J Clin Oncol       Date:  2018-04-20       Impact factor: 3.402

2.  Survey on the current gynaecological approach of ovarian cancer patients: The utility of HIPEC.

Authors:  Christos Iavazzo; Alexandros Fotiou; M Tsiatas; Athina Christopoulou; John Spiliotis; Paul Sugarbaker
Journal:  Pleura Peritoneum       Date:  2020-02-26

3.  Biological intensity-modulated radiotherapy plus neoadjuvant chemotherapy for multiple peritoneal metastases of ovarian cancer: A case report.

Authors:  Shigao Huang; Yazheng Dang; Fujun Li; Wei Wei; Yuxin Ma; Song Qiao; Qianyun Wang
Journal:  Oncol Lett       Date:  2014-12-22       Impact factor: 2.967

4.  Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery.

Authors:  Kyung Jin Eoh; Jung-Yun Lee; Jung Won Yoon; Eun Ji Nam; Sunghoon Kim; Sang-Wun Kim; Young Tae Kim
Journal:  Oncotarget       Date:  2017-06-06

5.  Delineation of retroperitoneal metastatic lymph nodes in ovarian cancer with near-infrared fluorescence imaging.

Authors:  Tao Pu; Liqin Xiong; Qiyu Liu; Minxing Zhang; Qingqing Cai; Haiou Liu; Anil K Sood; Guiling Li; Yu Kang; Congjian Xu
Journal:  Oncol Lett       Date:  2017-07-05       Impact factor: 2.967

6.  The relationship between retroperitoneal lymphadenectomy and survival in advanced ovarian cancer patients.

Authors:  Chenyan Fang; Yingli Zhang; Lingqin Zhao; Xi Chen; Liang Xia; Ping Zhang
Journal:  BMC Cancer       Date:  2020-07-13       Impact factor: 4.430

7.  Borderline tumours of the ovary: Common practice in the Netherlands.

Authors:  Koen De Decker; Henk G Ter Brugge; Joost Bart; Roy F P M Kruitwagen; Hans W Nijman; Arnold-Jan Kruse
Journal:  Gynecol Oncol Rep       Date:  2018-12-10

8.  Analysis of para-aortic lymphadenectomy up to the level of the renal vessels in apparent early-stage ovarian cancer.

Authors:  Suk-Joon Chang; Robert E Bristow; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2013-01-08       Impact factor: 4.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.